You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Digestive tract conditions
  5. Haemorrhoids and other anal conditions

Chronic anal fissure: botulinum toxin type A injection

  • Evidence summary
  • Reference number: ESUOM14
  • Published:  25 June 2013
  • Advice
  • Information for the public
Download (PDF)
  • Key points from the evidence
  • Overview for healthcare professionals
  • Relevance to NICE guidance programmes
  • Intervention and alternatives
  • Evidence review: efficacy
  • Evidence review: safety
  • Evidence review: economic issues
  • Evidence strengths and limitations
  • Summary for patients
  • References
  • Development of this evidence summary
  • Appendix: Search strategy and evidence selection
  • About 'Evidence summaries: unlicensed or off-label medicines'

Relevance to NICE guidance programmes

The use of botulinum toxin type A injection for treating chronic anal fissure is not appropriate for referral for a NICE technology appraisal because it is not licensed for this indication. It is not currently planned for any other NICE work programme.


Next page Intervention and alternatives Previous page Overview for healthcare professionals
Back to top